# μΆ…ν•© μ΄μ ν•΄κ²° κ³„νμ„
## 2025-09-26 κΈ°μ¤€ ν„μ¬ μƒν™© λ° μ΅°μΉ λ°©μ•

### π“‹ Executive Summary

**ν„μ¬ μƒνƒ**: P2 λ‹¨κ³„ μ™„λ£, λ² μ΄μ¤λΌμΈ ν™•λ³΄ μ„±κ³µ
**μ „μ²΄ ν’μ§**: 86.0% (GREEN)
**μ£Όμ” μ„±κ³Ό**:
- μΉμΈ μ‹μ¤ν… timeout μ΄μ ν•΄κ²° μ™„λ£
- λ² μ΄μ¤λΌμΈ ν…μ¤νΈ μ•μ •ν™” μ™„λ£ (Β±2.1% μ¬ν„μ„±)
- ES module νΈν™μ„± λ¬Έμ  ν•΄κ²°

**μ‹λ³„λ P2 μ΄μ**: 3κ° (μ—”ν‹°ν‹° μ»¤λ²„λ¦¬μ§€, μ§λ¬Έ μ ν• λ‹¤μ–‘μ„±, Evidence Quality)

---

## π¨ ν„μ¬ λ°κ²¬λ μ΄μ λ¶„μ„

### 1. HIGH Priority μ΄μ

#### 1.1 μ—”ν‹°ν‹° μ»¤λ²„λ¦¬μ§€ λ¶€μ΅± (P2)
- **ν„μ¬**: 33.6%
- **λ©ν‘**: 50.0%+
- **GAP**: -16.4%
- **μν–¥**: μ¤‘μ” λ„λ©”μΈ μ—”ν‹°ν‹°κ°€ QAμ—μ„ λ„λ½λ  μ„ν—
- **ν•΄κ²° λ°©μ•**:
  - Diversity Planner μ—μ΄μ „νΈ κ°μ„ 
  - Entity extraction λ²”μ„ ν™•λ€
  - Domain-specific entity list λ„μ…

#### 1.2 Evidence Quality κ°μ„  ν•„μ” (P2)
- **ν„μ¬**: Snippet Alignment 17.9%
- **λ©ν‘**: 60.0%+
- **GAP**: -42.1%
- **μν–¥**: Answerμ™€ Evidence κ°„ μ •λ ¬λ„ λ¶€μ΅±
- **ν•΄κ²° λ°©μ•**:
  - Evidence-Answer μ •λ ¬ μ•κ³ λ¦¬μ¦ κ°μ„ 
  - Snippet μ¶”μ¶ μ •ν™•λ„ ν–¥μƒ
  - Citation validation λ΅μ§ κ°•ν™”

### 2. MEDIUM Priority μ΄μ

#### 2.1 μ§λ¬Έ μ ν• λ¶κ· ν• (P2)
- **ν„μ¬**: comparison(10%), inference(2%)λ§ ν™μ©
- **λ„λ½**: factual, analytical, procedural, comparative
- **μν–¥**: QA λ°μ΄ν„°μ…‹ λ‹¤μ–‘μ„± λ¶€μ΅±
- **ν•΄κ²° λ°©μ•**:
  - Question Type Distribution ν¨ν„΄ μ¬μ΅°μ •
  - Target distribution μ¤€μ λ΅μ§ κ°•ν™”
  - Question template ν™•μ¥

---

## β… ν•΄κ²° μ™„λ£λ μ΄μ

### 1. Approval System Timeout κ°μ„  β…
**λ¬Έμ **: 90μ΄ νƒ€μ„μ•„μ›ƒμΌλ΅ μ¤‘μ” μ‘μ—…μ΄ μλ™ κ±΄λ„λ›°κΈ°λ¨
**ν•΄κ²°**:
- GPT μ΅°μ–Έ κΈ°λ° ν μ‹μ¤ν… λ„μ…
- νƒ€μ„μ•„μ›ƒ β†’ ν μ €μ¥μΌλ΅ λ³€κ²½
- λ¦¬μ¤ν¬λ³„ μ°¨λ“± νƒ€μ„μ•„μ›ƒ (P0=λ¬΄μ ν•, μ¤‘κ°„=90s, λ‚®μ=30s)
- λ΅¤λ°± μ „λµ κµ¬ν„

**νμΌ μ„μΉ**:
- `/scripts/lib/simplified-approval-system.ts` - λ©”μΈ λ΅μ§
- `/scripts/lib/approval-queue.ts` - ν μ‹μ¤ν…
- `/scripts/approve-queue.ts` - CLI μΈν„°νμ΄μ¤

### 2. Baseline Testing μ•μ •ν™” β…
**λ¬Έμ **: ES module νΈν™μ„±, Schema λ„λ½, null-safe access μ¤λ¥
**ν•΄κ²°**:
- 6κ° metrics νμΌ ES module μ§„μ…μ  μμ •
- `schema/baseline_report.schema.json` μƒμ„±
- null-safe μ ‘κ·Ό ν¨ν„΄ μ μ©
- μ¬ν„μ„± Β±2.1% λ‹¬μ„±

**νμΌ μ„μΉ**:
- `/scripts/metrics/*.ts` - ES module μμ •
- `/schema/baseline_report.schema.json` - μ¤ν‚¤λ§ μ •μ
- `/scripts/metrics/baseline_report_generator.ts` - null-safe μ μ©

---

## π“… λ‹¨κ³„λ³„ ν•΄κ²° λ΅λ“λ§µ

### Phase 1: P2 μ΄μ ν•΄κ²° (μ°μ„ μμ„)
**κΈ°κ°„**: 1-2μ£Ό
**λ©ν‘**: ν„μ¬ P2 μ΄μ 3κ° μ™„μ „ ν•΄κ²°

1. **μ—”ν‹°ν‹° μ»¤λ²„λ¦¬μ§€ κ°μ„ **
   - [ ] Entity extraction μ•κ³ λ¦¬μ¦ λ¶„μ„
   - [ ] Domain-specific entity λ©λ΅ κµ¬μ¶•
   - [ ] Diversity Planner λ΅μ§ κ°μ„ 
   - [ ] ν…μ¤νΈ: 50%+ μ»¤λ²„λ¦¬μ§€ λ‹¬μ„± ν™•μΈ

2. **Evidence Quality κ°μ„ **
   - [ ] Snippet alignment μ•κ³ λ¦¬μ¦ λ¶„μ„
   - [ ] N-gram κΈ°λ° μ •λ ¬ λ΅μ§ κ°μ„ 
   - [ ] Citation validation κ°•ν™”
   - [ ] ν…μ¤νΈ: 60%+ alignment λ‹¬μ„± ν™•μΈ

3. **μ§λ¬Έ μ ν• λ‹¤μ–‘μ„±**
   - [ ] Question pattern mapping μ¬μ΅°μ •
   - [ ] Target distribution κ°•μ  μ¤€μ λ΅μ§
   - [ ] Template ν™•μ¥ λ° κ²€μ¦
   - [ ] ν…μ¤νΈ: 4κ° μΉ΄ν…κ³ λ¦¬ κ· λ“± λ¶„ν¬ ν™•μΈ

### Phase 2: P3 μ›Ή μΈν„°νμ΄μ¤ κ°λ° (λ‹¤μ λ‹¨κ³„)
**κΈ°κ°„**: 2-3μ£Ό
**λ©ν‘**: μ‹¤μ‹κ°„ λ¨λ‹ν„°λ§ λ° λ¬Έμ„ μ—…λ΅λ“ μ‹μ¤ν…

1. **Next.js κΈ°λ° μ›Ή μ½μ†”**
   - [ ] λ² μ΄μ¤λΌμΈ λ¦¬ν¬νΈ μ‹¤μ‹κ°„ μ΅°ν
   - [ ] ν’μ§ μ§€ν‘ νΈλ λ“ μ‹κ°ν™”
   - [ ] P2 μ΄μ μ•λ¦Ό λ€μ‹λ³΄λ“

2. **λ¬Έμ„ μ—…λ΅λ“ & μ „λ¬Έκ°€ ν”Όλ“λ°±**
   - [ ] λ“λκ·Έμ•¤λ“λ΅­ μ—…λ΅λ“ μΈν„°νμ΄μ¤
   - [ ] QA μƒμ„± μ›ν¬ν”λ΅μ°
   - [ ] μ „λ¬Έκ°€ ν”Όλ“λ°± μμ§‘ μ‹μ¤ν…

---

## π”§ κΈ°μ μ  μ΅°μΉ μ‚¬ν•­

### μ¦‰μ‹ μ΅°μΉ (μ΄λ² μ£Ό)
1. **λ¨λ‹ν„°λ§ κ°•ν™”**
   - ν„μ¬ baseline report μ •κΈ° μƒμ„± μ¤μΌ€μ¤„λ§
   - P2 μ΄μ μ„κ³„κ°’ μ•λ¦Ό μ„¤μ •
   - ν’μ§ μ§€ν‘ νΈλ λ“ μ¶”μ 

2. **λ¬Έμ„ μ •λ¦¬**
   - PRODUCT_PLAN.md μ—…λ°μ΄νΈ μ™„λ£ β…
   - μ΄μ ν•΄κ²° μ§„ν–‰ μƒν™© μ¶”μ  μ‹μ¤ν…
   - RFC/ADR λ¬Έμ„ μƒμ„± (ν•„μ”μ‹)

### μ¤‘κΈ° μ΅°μΉ (2-4μ£Ό)
1. **μ—μ΄μ „νΈ κ°μ„ **
   - Diversity Planner λ΅μ§ μ¬κµ¬μ„±
   - Evidence Quality μ•κ³ λ¦¬μ¦ μµμ ν™”
   - Question Type Distribution μ—”μ§„ κ°μ„ 

2. **μΈν”„λΌ κ°•ν™”**
   - μ›Ή μΈν„°νμ΄μ¤ κµ¬μ¶•
   - μ‹¤μ‹κ°„ λ¨λ‹ν„°λ§ μ‹μ¤ν…
   - μλ™ν™”λ ν’μ§ κ²μ΄νΈ

---

## π“ μ„±κ³µ μ§€ν‘ λ° KPI

### P2 μ΄μ ν•΄κ²° KPI
- **μ—”ν‹°ν‹° μ»¤λ²„λ¦¬μ§€**: 33.6% β†’ 50%+ (λ©ν‘)
- **Evidence Quality**: 17.9% β†’ 60%+ (λ©ν‘)
- **μ§λ¬Έ μ ν• λ‹¤μ–‘μ„±**: 2κ° β†’ 4κ° μΉ΄ν…κ³ λ¦¬ κ· λ“± λ¶„ν¬
- **μ „μ²΄ ν’μ§ μ μ**: 86.0% β†’ 90%+ μ μ§€

### μ‹μ¤ν… μ•μ •μ„± KPI
- **μ¬ν„μ„±**: Β±2.1% μ μ§€ (λ©ν‘ Β±5% μ΄λ‚΄)
- **μ‘λ‹µ μ‹κ°„**: P95 241ms μ μ§€
- **λΉ„μ© ν¨μ¨μ„±**: $0.0010/item μ μ§€
- **μ—λ¬μ¨**: 0% μ μ§€

---

## π€ Next Actions

### μ΄λ² μ£Ό μ°μ„ μμ„
1. **μ—”ν‹°ν‹° μ»¤λ²„λ¦¬μ§€ λ¶„μ„ μ‹μ‘**
   - ν„μ¬ entity extraction λ΅μ§ λ¶„μ„
   - λ„λ½λ μ¤‘μ” μ—”ν‹°ν‹° μ‹λ³„
   - κ°μ„  λ°©μ• μ„¤κ³„

2. **Evidence Quality μ›μΈ λ¶„μ„**
   - Snippet alignment μ‹¤ν¨ μΌ€μ΄μ¤ λ¶„μ„
   - N-gram overlap μµμ ν™” λ°©μ• μ—°κµ¬
   - Citation validation λ΅μ§ κ²€ν† 

3. **P3 μ›Ή μΈν„°νμ΄μ¤ μ„¤κ³„**
   - Next.js ν”„λ΅μ νΈ κµ¬μ΅° μ„¤κ³„
   - μ‹¤μ‹κ°„ λ¨λ‹ν„°λ§ μ”κµ¬μ‚¬ν•­ μ •μ
   - UI/UX μ™€μ΄μ–΄ν”„λ μ„ μ‘μ„±

### λ‹¤μ μ£Ό κ³„ν
1. **μ‹¤μ  μ½”λ“ κµ¬ν„ μ‹μ‘**
2. **ν…μ¤νΈ μΌ€μ΄μ¤ μ‘μ„± λ° κ²€μ¦**
3. **μ›Ή μΈν„°νμ΄μ¤ ν”„λ΅ν† νƒ€μ… κ°λ°**

---

## π“ Handoff Information

μ΄ λ¬Έμ„λ” λ‹¤λ¥Έ κ°λ°μλ‚ LLMμ—κ² ν„μ¬ μƒν™©μ„ μ „λ‹¬ν•  λ• μ‚¬μ©ν•  ν•µμ‹¬ μ •λ³΄λ¥Ό λ‹΄κ³  μμµλ‹λ‹¤.

**ν•µμ‹¬ ν¬μΈνΈ**:
- P2 λ‹¨κ³„ μ„±κ³µμ  μ™„λ£, 3κ° ν’μ§ μ΄μ μ‹λ³„
- Approval/baseline testing μ•μ •ν™” μ™„λ£
- P3 λ‹¨κ³„ μ§„ν–‰ μ¤€λΉ„ μ™„λ£
- κµ¬μ²΄μ  ν•΄κ²° λ°©μ•κ³Ό KPI μ •μλ¨

**μ°Έμ΅° λ¬Έμ„**:
- `docs/PRODUCT_PLAN.md` (μ „μ²΄ λ΅λ“λ§µ)
- `reports/baseline_report.md` (ν„μ¬ μ„±λ¥ μ§€ν‘)
- `CLAUDE.md` (μ‹μ¤ν… μ² ν•™ λ° ν‘μ¤€)

---

*Generated: 2025-09-26*
*Next Update: Weekly or upon major milestone completion*